Methotrexate (oral)
- Coding system
- Dictionary of Medicines and Devices
- Coding system release
- unknown
- Organisation
- OpenSAFELY
- Codelist ID
- opensafely/methotrexate-oral
- Version ID
- 1d29f655
Versions
Description
dm+d codelist for oral methotrexate
Methodology
This codelist was developed based on methodology used in the DataLab paper on trends and variation in unsafe prescribing of methotrexate published in the British Journal of General Practice. All oral methotrexate preparations from chapter 10 of BNF codes were included although the vast majority of prescriptions will be for tablets. You can view the BNF codelist version here
References
Signed off by
- Brian MacKenna, (March 3, 2021)
- Richard Croker, (March 3, 2021)
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
* dm+d codelists can be downloaded with codes mapped to changed VMPs included - this is the default for an OpenSAFELY project. See the documentation on keeping codelists up to date for more details.
| dmd_type | dmd_id | dmd_name | bnf_code |
|---|---|---|---|
| VMP | 1.28169E+16 | Methotrexate 25mg/5ml oral solution | 1001030U0AAAAAA |
| VMP | 1.2817E+16 | Methotrexate 25mg/5ml oral suspension | 1001030U0AAAAAA |
| AMP | 1.28009E+16 | Methotrexate 25mg/5ml oral solution | 1001030U0AAAAAA |
| AMP | 1.28006E+16 | Methotrexate 25mg/5ml oral suspension | 1001030U0AAAAAA |
| VMP | 326874007 | Methotrexate 2.5mg tablets | 1001030U0AAABAB |
| AMP | 2.01811E+14 | Methotrexate 2.5mg tablets | 1001030U0AAABAB |
| AMP | 6.83611E+14 | Methotrexate 2.5mg tablets | 1001030U0AAABAB |
| AMP | 7.06911E+14 | Methotrexate 2.5mg tablets | 1001030U0AAABAB |
| AMP | 3.49566E+16 | Methotrexate 2.5mg tablets | 1001030U0AAABAB |
| AMP | 2.43816E+16 | Methotrexate 2.5mg tablets | 1001030U0AAABAB |
| AMP | 1.67911E+14 | Methotrexate 2.5mg tablets | 1001030U0AAABAB |
| AMP | 3.72732E+16 | Methotrexate 2.5mg tablets | 1001030U0AAABAB |
| AMP | 2.4136E+16 | Methotrexate 2.5mg tablets | 1001030U0AAABAB |
| AMP | 1.49625E+16 | Methotrexate 2.5mg tablets | 1001030U0AAABAB |
| AMP | 3.83711E+14 | Methotrexate 2.5mg tablets | 1001030U0AAABAB |
| AMP | 2.03106E+16 | Methotrexate 2.5mg tablets | 1001030U0AAABAB |
| AMP | 2.99189E+16 | Methotrexate 2.5mg tablets | 1001030U0AAABAB |
| AMP | 2.22223E+16 | Methotrexate 2.5mg tablets | 1001030U0AAABAB |
| AMP | 2.17962E+16 | Methotrexate 2.5mg tablets | 1001030U0AAABAB |
| AMP | 1.10264E+16 | Methotrexate 2.5mg tablets | 1001030U0AAABAB |
| VMP | 326875008 | Methotrexate 10mg tablets | 1001030U0AAACAC |
| AMP | 9.28011E+14 | Methotrexate 10mg tablets | 1001030U0AAACAC |
| AMP | 1.36411E+14 | Methotrexate 10mg tablets | 1001030U0AAACAC |
| AMP | 2.43814E+16 | Methotrexate 10mg tablets | 1001030U0AAACAC |
| AMP | 2.41357E+16 | Methotrexate 10mg tablets | 1001030U0AAACAC |
| AMP | 1.49639E+16 | Methotrexate 10mg tablets | 1001030U0AAACAC |
| AMP | 1.91111E+14 | Methotrexate 10mg tablets | 1001030U0AAACAC |
| AMP | 2.03108E+16 | Methotrexate 10mg tablets | 1001030U0AAACAC |
| AMP | 1.51094E+16 | Methotrexate 10mg tablets | 1001030U0AAACAC |
| AMP | 2.22221E+16 | Methotrexate 10mg tablets | 1001030U0AAACAC |
| AMP | 2.17965E+16 | Methotrexate 10mg tablets | 1001030U0AAACAC |
| AMP | 1.10266E+16 | Methotrexate 10mg tablets | 1001030U0AAACAC |
| VMP | 8.66561E+15 | Methotrexate 2.5mg/5ml oral solution | 1001030U0AAAEAE |
| VMP | 8.66571E+15 | Methotrexate 2.5mg/5ml oral suspension | 1001030U0AAAEAE |
| AMP | 8.62271E+15 | Methotrexate 2.5mg/5ml oral solution | 1001030U0AAAEAE |
| AMP | 8.62421E+15 | Methotrexate 2.5mg/5ml oral suspension | 1001030U0AAAEAE |
| VMP | 8.66581E+15 | Methotrexate 5mg/5ml oral solution | 1001030U0AAAFAF |
| VMP | 8.66591E+15 | Methotrexate 5mg/5ml oral suspension | 1001030U0AAAFAF |
| AMP | 8.62591E+15 | Methotrexate 5mg/5ml oral solution | 1001030U0AAAFAF |
| AMP | 8.62651E+15 | Methotrexate 5mg/5ml oral suspension | 1001030U0AAAFAF |
| VMP | 8.66491E+15 | Methotrexate 10mg/5ml oral solution | 1001030U0AAAHAH |
| VMP | 8.66501E+15 | Methotrexate 10mg/5ml oral suspension | 1001030U0AAAHAH |
| AMP | 8.61811E+15 | Methotrexate 10mg/5ml oral solution | 1001030U0AAAHAH |
| AMP | 8.61881E+15 | Methotrexate 10mg/5ml oral suspension | 1001030U0AAAHAH |
| VMP | 8.66601E+15 | Methotrexate 7.5mg/5ml oral solution | 1001030U0AAAIAI |
| VMP | 8.66611E+15 | Methotrexate 7.5mg/5ml oral suspension | 1001030U0AAAIAI |
| AMP | 8.62581E+15 | Methotrexate 7.5mg/5ml oral solution | 1001030U0AAAIAI |
| AMP | 8.62641E+15 | Methotrexate 7.5mg/5ml oral suspension | 1001030U0AAAIAI |
| VMP | 1.28171E+16 | Methotrexate 3.75mg/5ml oral solution | 1001030U0AAAJAJ |
| VMP | 1.28172E+16 | Methotrexate 3.75mg/5ml oral suspension | 1001030U0AAAJAJ |
| AMP | 1.28015E+16 | Methotrexate 3.75mg/5ml oral solution | 1001030U0AAAJAJ |
| AMP | 1.28012E+16 | Methotrexate 3.75mg/5ml oral suspension | 1001030U0AAAJAJ |
| VMP | 8.66511E+15 | Methotrexate 12.5mg/5ml oral solution | 1001030U0AAAKAK |
| VMP | 8.66521E+15 | Methotrexate 12.5mg/5ml oral suspension | 1001030U0AAAKAK |
| AMP | 8.61931E+15 | Methotrexate 12.5mg/5ml oral solution | 1001030U0AAAKAK |
| AMP | 8.61961E+15 | Methotrexate 12.5mg/5ml oral suspension | 1001030U0AAAKAK |
| VMP | 1.28145E+16 | Methotrexate 1mg/5ml oral solution | 1001030U0AAALAL |
| VMP | 1.28146E+16 | Methotrexate 1mg/5ml oral suspension | 1001030U0AAALAL |
| AMP | 1.27967E+16 | Methotrexate 1mg/5ml oral solution | 1001030U0AAALAL |
| AMP | 1.27964E+16 | Methotrexate 1mg/5ml oral suspension | 1001030U0AAALAL |
| VMP | 1.28156E+16 | Methotrexate 7mg/5ml oral solution | 1001030U0AAAMAM |
| VMP | 1.28157E+16 | Methotrexate 7mg/5ml oral suspension | 1001030U0AAAMAM |
| AMP | 1.28057E+16 | Methotrexate 7mg/5ml oral solution | 1001030U0AAAMAM |
| AMP | 1.28051E+16 | Methotrexate 7mg/5ml oral suspension | 1001030U0AAAMAM |
| VMP | 1.28175E+16 | Methotrexate 50mg/5ml oral solution | 1001030U0AAANAN |
| VMP | 1.28151E+16 | Methotrexate 50mg/5ml oral suspension | 1001030U0AAANAN |
| AMP | 1.2803E+16 | Methotrexate 50mg/5ml oral solution | 1001030U0AAANAN |
| AMP | 1.28026E+16 | Methotrexate 50mg/5ml oral suspension | 1001030U0AAANAN |
| VMP | 1.28158E+16 | Methotrexate 8mg/5ml oral solution | 1001030U0AAAPAP |
| VMP | 1.28159E+16 | Methotrexate 8mg/5ml oral suspension | 1001030U0AAAPAP |
| AMP | 1.28066E+16 | Methotrexate 8mg/5ml oral solution | 1001030U0AAAPAP |
| AMP | 1.28063E+16 | Methotrexate 8mg/5ml oral suspension | 1001030U0AAAPAP |
| VMP | 1.28154E+16 | Methotrexate 750micrograms/5ml oral solution | 1001030U0AAAQAQ |
| VMP | 1.28155E+16 | Methotrexate 750micrograms/5ml oral suspension | 1001030U0AAAQAQ |
| AMP | 1.28046E+16 | Methotrexate 750micrograms/5ml oral solution | 1001030U0AAAQAQ |
| AMP | 1.2804E+16 | Methotrexate 750micrograms/5ml oral suspension | 1001030U0AAAQAQ |
| VMP | 8.66531E+15 | Methotrexate 15mg/5ml oral solution | 1001030U0AAARAR |
| VMP | 8.66541E+15 | Methotrexate 15mg/5ml oral suspension | 1001030U0AAARAR |
| AMP | 8.61991E+15 | Methotrexate 15mg/5ml oral solution | 1001030U0AAARAR |
| AMP | 8.62031E+15 | Methotrexate 15mg/5ml oral suspension | 1001030U0AAARAR |
| VMP | 1.28139E+16 | Methotrexate 12mg/5ml oral solution | 1001030U0AAASAS |
| VMP | 1.2814E+16 | Methotrexate 12mg/5ml oral suspension | 1001030U0AAASAS |
| AMP | 1.2794E+16 | Methotrexate 12mg/5ml oral solution | 1001030U0AAASAS |
| AMP | 1.27937E+16 | Methotrexate 12mg/5ml oral suspension | 1001030U0AAASAS |
| VMP | 1.28141E+16 | Methotrexate 17.5mg/5ml oral solution | 1001030U0AAATAT |
| VMP | 1.28142E+16 | Methotrexate 17.5mg/5ml oral suspension | 1001030U0AAATAT |
| AMP | 1.27946E+16 | Methotrexate 17.5mg/5ml oral solution | 1001030U0AAATAT |
| AMP | 1.27943E+16 | Methotrexate 17.5mg/5ml oral suspension | 1001030U0AAATAT |
| VMP | 1.28173E+16 | Methotrexate 4mg/5ml oral solution | 1001030U0AAAUAU |
| VMP | 1.28174E+16 | Methotrexate 4mg/5ml oral suspension | 1001030U0AAAUAU |
| AMP | 1.28022E+16 | Methotrexate 4mg/5ml oral solution | 1001030U0AAAUAU |
| AMP | 1.28019E+16 | Methotrexate 4mg/5ml oral suspension | 1001030U0AAAUAU |
| VMP | 1.28147E+16 | Methotrexate 20mg/5ml oral solution | 1001030U0AAAVAV |
| VMP | 1.28148E+16 | Methotrexate 20mg/5ml oral suspension | 1001030U0AAAVAV |
| AMP | 1.27986E+16 | Methotrexate 20mg/5ml oral solution | 1001030U0AAAVAV |
| AMP | 1.27982E+16 | Methotrexate 20mg/5ml oral suspension | 1001030U0AAAVAV |
| VMP | 1.28152E+16 | Methotrexate 6mg/5ml oral solution | 1001030U0AAAWAW |
| VMP | 1.28153E+16 | Methotrexate 6mg/5ml oral suspension | 1001030U0AAAWAW |
| AMP | 1.28036E+16 | Methotrexate 6mg/5ml oral solution | 1001030U0AAAWAW |
| AMP | 1.28033E+16 | Methotrexate 6mg/5ml oral suspension | 1001030U0AAAWAW |
| VMP | 1.28143E+16 | Methotrexate 18mg/5ml oral solution | 1001030U0AAAXAX |
| VMP | 1.28144E+16 | Methotrexate 18mg/5ml oral suspension | 1001030U0AAAXAX |
| AMP | 1.27961E+16 | Methotrexate 18mg/5ml oral solution | 1001030U0AAAXAX |
| AMP | 1.27958E+16 | Methotrexate 18mg/5ml oral suspension | 1001030U0AAAXAX |
| VMP | 1.28149E+16 | Methotrexate 22.5mg/5ml oral solution | 1001030U0AAAYAY |
| VMP | 1.2815E+16 | Methotrexate 22.5mg/5ml oral suspension | 1001030U0AAAYAY |
| AMP | 1.28001E+16 | Methotrexate 22.5mg/5ml oral solution | 1001030U0AAAYAY |
| AMP | 1.27997E+16 | Methotrexate 22.5mg/5ml oral suspension | 1001030U0AAAYAY |
| VMP | 3.07999E+16 | Methotrexate 2mg/ml oral solution sugar free | 1001030U0AACFCF |
| AMP | 3.1065E+16 | Methotrexate 2mg/ml oral solution sugar free | 1001030U0AACFCF |
| AMP | 3.09852E+16 | Methotrexate 2mg/ml oral solution sugar free | 1001030U0AACFCF |
| AMP | 3.74507E+16 | Methotrexate 2mg/ml oral solution sugar free | 1001030U0AACFCF |
| AMP | 3.05951E+16 | Methotrexate 2mg/ml oral solution sugar free | 1001030U0AACFCF |
| AMP | 6.44711E+14 | Maxtrex 2.5mg tablets | 1001030U0BDAAAB |
| AMP | 3.22011E+14 | Maxtrex 10mg tablets | 1001030U0BDABAC |
| AMP | 3.4871E+16 | Jylamvo 2mg/ml oral solution | 1001030U0BHAACF |
* Note that this is the full list of explicitly included dm+d codes for this codelist. An OpenSAFELY project will by default also include previous or subsequent codes for any included VMPs that may have changed code. See the documentation on keeping codelists up to date for more details.